Home › Funds › Parkman Healthcare Partners LLC › PODD

Parkman Healthcare Partners LLC position in PODD

INSULET CORP · Health Care

Parkman Healthcare Partners LLC reported holding 131,378 shares of PODD (INSULET CORP) in its Q2 2026 13F filing — a position valued at US$20.0M, representing 2.05% of its reported portfolio and ranking #17 among its reported holdings. Parkman Healthcare Partners LLC has disclosed PODD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)131.38K sh
Reported value held$20.00M
Portfolio Weight2.05%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Parkman Healthcare Partners LLC's PODD position evolved

Parkman Healthcare Partners LLC first disclosed a stake in PODD in Q3 2023 at 42,025 shares (US$6.7M). The position peaked in Q4 2025 at 140,860 shares, worth US$40.0M. Across 12 filings, Parkman Healthcare Partners LLC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 131,378 shares valued at US$20.0M — a reduction of -25,183 shares quarter over quarter.. Notable position changes include a 111% increase in Q4 2023 (shares fell 21% over the following quarter), a 97% increase in Q2 2024 (shares rose 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 42.02K $6.70M New
Q4 2023 88.67K $19.24M Add
Q1 2024 90.95K $15.59M Add
Q2 2024 179.31K $36.18M Add
Q3 2024 159.69K $37.17M Reduce
Q4 2024 125.76K $32.83M Reduce
Q1 2025 130.51K $34.27M Add
Q2 2025 105.76K $33.23M Reduce
Q3 2025 116.24K $35.89M Add
Q4 2025 140.86K $40.04M Add
Q1 2026 156.56K $32.85M Add
Q2 2026 131.38K $20.00M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PODD and 13F data

PODD (INSULET CORP) is a Health Care company. 29 other funds we track also report a position in PODD — the largest reported positions include Two Sigma Investments (US$289.8M), Soleus Capital Management, L.P. (US$159.7M), JUPITER ASSET MANAGEMENT LTD (US$156.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PODD

All PODD fund holders →

FAQ

How long has Parkman Healthcare Partners LLC held PODD?

Parkman Healthcare Partners LLC has disclosed PODD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Parkman Healthcare Partners LLC's current position in PODD?

As of Q2 2026, Parkman Healthcare Partners LLC holds 131.38K shares of PODD (INSULET CORP), valued at $20.00M, representing 2.05% of its reported portfolio and ranking #17.

Has Parkman Healthcare Partners LLC been buying or selling PODD?

In the latest 13F filing (Q2 2026), Parkman Healthcare Partners LLC reduced its position in PODD. The position peaked in Q4 2025 at 140.86K shares.

Which other funds hold PODD?

Other major institutional holders of PODD include Two Sigma Investments, Soleus Capital Management, L.P., JUPITER ASSET MANAGEMENT LTD, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.